Kevin Enzweiler

New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 1. 7-<i>tert</i>-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents:  Discovery and Variation of the 5-Keto Substituent

John M. Janusz, Patricia A. Young, James M. Ridgeway et al. · Journal of Medicinal Chemistry · 1998 · 53 citations · Full text

Pharmacotherapy, New Cyclooxygenase-2/5-lipoxygenase Inhibitors, Pharmaceutical Chemistry +16

New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 3. 7-<i>tert</i>-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents:  Variations at the 5 Position

John M. Janusz, Patricia A. Young, James M. Ridgeway et al. · Journal of Medicinal Chemistry · 1998 · 44 citations · Full text

Bioorganic Chemistry, Gastrointestinal Pharmacology, Dual Cyclooxygenase +19

New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 2. 7-<i>tert</i>-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents:  Variations of the Dihydrobenzofuran Ring

John M. Janusz, Patricia A. Young, Michael W. Scherz et al. · Journal of Medicinal Chemistry · 1998 · 34 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Heterocycle Chemistry +21

Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999–2000

Roger L. White, Kevin Enzweiler, Lawrence V. Friedrich et al. · Diagnostic Microbiology and Infectious Disease · 2002 · 17 citations

Comparative Activity, Antimicrobial Susceptibility, Antimicrobial Stewardship +11